Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonists
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonists
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-17
DOI
10.1038/s41467-022-28561-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 107-LB: Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1092 in Healthy Subjects (HS)
- (2020) LINDA MORROW et al. DIABETES
- 106-LB: Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1092 in Subjects with T1DM and T2DM
- (2020) LINDA MORROW et al. DIABETES
- Conformational Basis of G Protein-Coupled Receptor Signaling Versatility
- (2020) Laura M. Wingler et al. TRENDS IN CELL BIOLOGY
- Review: Glucose-sensitive insulin
- (2020) Thomas Hoeg-Jensen Molecular Metabolism
- Activation mechanism of the insulin receptor revealed by cryo-EM structure of the fully liganded receptor–ligand complex
- (2019) Emiko Uchikawa et al. eLife
- Cryo-EM structure of the complete and ligand-saturated insulin receptor ectodomain
- (2019) Theresia Gutmann et al. JOURNAL OF CELL BIOLOGY
- Structure of the insulin receptor–insulin complex by single-particle cryo-EM analysis
- (2018) Giovanna Scapin et al. NATURE
- Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety
- (2018) Paola Ponzani et al. Diabetes Therapy
- Endothelial insulin receptors differentially control insulin signaling kinetics in peripheral tissues and brain of mice
- (2017) Masahiro Konishi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective Insulin Resistance and the Development of Cardiovascular Diseases in Diabetes: The 2015 Edwin Bierman Award Lecture
- (2016) George L. King et al. DIABETES
- Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes
- (2016) K. Cusi et al. DIABETES OBESITY & METABOLISM
- Higher-Resolution Structure of the Human Insulin Receptor Ectodomain: Multi-Modal Inclusion of the Insert Domain
- (2016) Tristan I. Croll et al. STRUCTURE
- How Can a Good Idea Fail? Basal Insulin Peglispro [LY2605541] for the Treatment of Type 2 Diabetes
- (2016) Araceli Muñoz-Garach et al. Diabetes Therapy
- How Can a Good Idea Fail? Basal Insulin Peglispro [LY2605541] for the Treatment of Type 2 Diabetes
- (2016) Araceli Muñoz-Garach et al. Diabetes Therapy
- Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5
- (2015) John B. Buse et al. DIABETES CARE
- New forms of insulin and insulin therapies for the treatment of type 2 diabetes
- (2015) Avivit Cahn et al. Lancet Diabetes & Endocrinology
- Identification of a Small Molecular Insulin Receptor Agonist With Potent Antidiabetes Activity
- (2014) G. Qiang et al. DIABETES
- Diabetes and Cardiovascular Disease in Older Adults: Current Status and Future Directions
- (2014) J. B. Halter et al. DIABETES
- Different Epidermal Growth Factor (EGF) Receptor Ligands Show Distinct Kinetics and Biased or Partial Agonism for Homodimer and Heterodimer Formation
- (2014) Jennifer L. Macdonald-Obermann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Allosteric targeting of receptor tyrosine kinases
- (2014) Frederik De Smet et al. NATURE BIOTECHNOLOGY
- Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor Signaling
- (2013) Corentin Herbert et al. CANCER CELL
- Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect on Glucose Metabolism
- (2013) M. C. Moore et al. DIABETES
- Hepatoselectivity and the evolution of insulin
- (2013) R. Herring et al. DIABETES OBESITY & METABOLISM
- Increased Mortality of Patients With Diabetes Reporting Severe Hypoglycemia
- (2012) R. G. McCoy et al. DIABETES CARE
- Insulin Therapy and Hypoglycemia
- (2012) Anthony L. McCall ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action
- (2009) E. J. Barrett et al. DIABETOLOGIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started